Veeva Systems Inc.
NYSE:VEEVMedical - Healthcare Information Services
-$2.83 today
- Market cap
- $44.88B
- Beta
- 0.95
- P/E (TTM)
- 26.4
- EPS (TTM)
- $5.76
Volume 2.74M
Average 3.01M
VEEV Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Veeva Systems Inc.NYSE: VEEV
Gross Margin · Q2 FY2027 · quarter ended Jul 2026
Gross margin holds steady near 75.0%
Gross margin was 75.0% in Q2 FY2027, down 0.3 pp from a year earlier. On a trailing-twelve-month basis it was 74.9%, down 0.7 pp year over year. Over 3 fiscal years it widened by 3.8 pp.
Context
- Gross margin widened in 2 of the last 3 fiscal years.
- FY2026 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2026
- 75.5%
- Year-over-year change
- +1.0pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 75.5% | +1.0pp |
| FY2025 | 2025-01-31 | 74.5% | +3.2pp |
| FY2024 | 2024-01-31 | 71.3% | -0.4pp |
| FY2023 | 2023-01-31 | 71.7% | -1.1pp |
| FY2022 | 2022-01-31 | 72.8% | — |
Gross Margin vs competitors
How VEEV compares with its peers on the latest reported figures
- VEEV's LTM Jul 2026 gross margin of 74.9% is the 2nd highest of the 5 companies compared; the peer median is 61.7%.
- Its year-over-year change of -0.7 pp is the 2nd highest of 5, against a peer median of -2.3 pp.
- Over three fiscal years its change of +3.8 pp compares with a peer median of -0.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 86.8% | -3.4 pp | +1.9 pp | |
| LTM Jul 2026 | 74.9% | -0.7 pp | +3.8 pp | |
| LTM Mar 2026 | 64.9% | -1.3 pp | -1.1 pp | |
| LTM Sep 2026 | 58.5% | +0.4 pp | -0.1 pp | |
| LTM Jun 2026 | 26.2% | -8.0 pp | -1.6 pp | |
| Peer median (excluding VEEV) | 61.7% | -2.3 pp | -0.6 pp | |
Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.85B | 2.16B | 2.36B | 2.75B | 3.2B |
| Cost of Revenue | 503.68M | 609.41M | 677.29M | 699.64M | 782.02M |
| Gross Profit | 1.35B | 1.55B | 1.69B | 2.05B | 2.41B |
| Gross Margin | 72.8% | 71.7% | 71.3% | 74.5% | 75.5% |
| Research & Development | 382.04M | 520.28M | 629.03M | 693.08M | 767.39M |
| Selling, General & Admin | 459.57M | 566.29M | 628.02M | 662.47M | 729.54M |
| Operating Expenses | 841.6M | 1.09B | 1.26B | 1.36B | 1.5B |
| Depreciation & Amortization | 27.45M | 29.12M | 32.63M | 39.38M | 50.47M |
| EBITDA | 539.76M | 538.22M | 620.65M | 958.76M | 1.24B |
| EBITDA Margin | 29.2% | 25.0% | 26.3% | 34.9% | 39.0% |
| Operating Income | 505.5M | 459.09M | 429.33M | 691.44M | 916.37M |
| Operating Margin | 27.3% | 21.3% | 18.2% | 25.2% | 28.7% |
| Interest Income | 14.73M | 45.86M | 133.75M | 207.99M | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 6.82M | 50.01M | 158.69M | 227.95M | 278.14M |
| Income Before Tax | 512.31M | 509.1M | 588.02M | 919.38M | 1.19B |
| Pre-Tax Margin | 27.7% | 23.6% | 24.9% | 33.5% | 37.4% |
| Income Tax Expense | 84.92M | 21.39M | 62.32M | 205.24M | 285.6M |
| Net Income | 427.39M | 487.71M | 525.71M | 714.14M | 908.91M |
| Net Margin | 23.1% | 22.6% | 22.2% | 26.0% | 28.4% |
| EPS (Basic) | 2.79 | 3.14 | 3.27 | 4.41 | 5.55 |
| EPS (Diluted) | 2.63 | 3.00 | 3.22 | 4.32 | 5.44 |
| Weighted Avg Shares | 153.25M | 155.39M | 160.53M | 161.88M | 163.67M |
| Weighted Avg Shares (Diluted) | 162.28M | 162.44M | 163.49M | 165.23M | 167M |
Veeva Systems Inc.
NYSE:VEEV
Intrinsic Alpha fair value
Locked
Current Price
$277.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.